Replimune
Presencia
Replimune es una de las ...
Replimune es una empresa que cotiza bajo el símbolo de cotización REPL (US).
Ejecutivos
Ver el organigrama con sus 18 ejecutivos principales
Biografías más buscadas en Replimune
- Sushil Patel, Chief Executive Officer
- Dieter Weinand, Chairman of the Board
- Philip Astley-Sparke, Executive Chairman of the Board
Recientes movimientos de ejecutivos en Replimune
- Sushil Patel que ha sido Chief Strategy Officer, ha ascendido a Chief Executive Officer (noticia publicada el 26 de marzo de 2024).
- Emily Hill, se ha incorporado a la empresa como Chief Financial Officer (noticia publicada el 20 de septiembre de 2023).
- Sander Slootweg, Director, ha dejado la empresa (noticia publicada el 21 de julio de 2023).
Crear su alerta
para seguir los movimientos de los ejecutivos en Replimune.
Biotecnología
Replimune tiene 2.276 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnología
- Histogen has filed for bankruptcy protection (publicado el 19 de abril de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado el 18 de abril de 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (publicado el 16 de abril de 2024).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Replimune
- Replimune Announces Pricing of Upsized Public Offering | Replimune
- Replimune Releases Updated Corporate Presentation | Replimune
- Replimune Announces Proposed Public Offering | Replimune
- Replimune Appoints Tanya Lewis to the Board of Directors | Replimune
- Replimune Announces Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting | Replimune
- Replimune to Participate at the Chardan Virtual 4th Annual Genetic Medicines Conference | Replimune
- Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update | Replimune
- Replimune to Present at Two Upcoming Investor Conferences | Replimune
- Replimune Appoints Andrea Pirzkall, M.D. as Chief Medical Officer | Replimune
- Replimune to Participate at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference | Replimune
- View more press releases Close
Redes sociales sobre Replimune
- Replimune en Wikipedia, Google News y Yahoo Finance
- Replimune en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Sushil Patel 
Llame a Replimune al +1 617...
